Increasing the value of genomic medicine through private pharmacogenomic reporting
Ended Project Grant Awarded Last action
- Award ID
- R43LM014350
- Recipient
-
Geneial LLC UEI RG9ZC5CLCH56
- Awarding agency
-
National Institute of Environmental Health Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $349,432
Award facts
- Assistance listing
- 93.879 Medical Library Assistance
- Completion date
- Originally
- Place of performance
- Texas, USA
Award details come from USAspending.gov.
Description
- Abstract
- Genomic sequencing promises to transform medicine, yet the current economics of genetic and genomic testing prohibit widespread adoption. Of particular interest is pharmacogenomics (PGX), with the potential to transform precision medicine through understanding gene-drug-disease associations, mapping of drug pathways, identification of drug targets, and minimization of drug toxicities. Despite its potential, PGX has yet to be widely implemented in clinical care and is hindered by high costs of genomic sequencing, lack of standardized and interoperable data, and lack of clinician education in interpreting complex genomic reports. We aim to solve these problems through the development of a hipaa-compliant, privacy-preserving PGX platform in which patients can maintain ownership and transactional-level control of data use, thereby protecting patient privacy while facilitating use and reuse of genomic data. This tool will include streamlined report generation, an encrypted database supporting encrypted queries against PGX data, and access via API or user-friendly web and mobile applications. Our innovative encryption technology offers an unprecedented level of privacy, never exposing unencrypted sensitive data to third parties (e.g. data storage or compute providers) or other intermediaries. Additionally, by only delivering the standardized data needed for a given context, interoperability and integration with existing clinical workflows (e.g. EHR or clinical decision support platforms) is streamlined and the burden of clinicians to independently analyze lengthy or complex reports is reduced. Ultimately, this project aims to increase the value of genomic sequencing and the availability of standardized PGX data at the point of care.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $349,432 |
Quick answers
Who received award R43LM014350?
R43LM014350 was awarded to Geneial LLC by National Institute of Environmental Health Sciences (National Institutes of Health) on September 7, 2023.
How much is award R43LM014350 worth?
$349,432 has been obligated on R43LM014350.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award